(Q37789757)

23 August 2017

0 references

Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation (English)

1 reference

23 August 2017

Donna Seger

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

48

1 reference

23 August 2017

issue

7

1 reference

23 August 2017

page(s)

695-708

1 reference

A 28-year-old man addicted to cocaine

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Addiction, dopamine, and the molecular mechanisms of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Molecular basis of long-term plasticity underlying addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Drug abuse: hedonic homeostatic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Addiction and the brain: The neurobiology of compulsion and its persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

New insights into dopaminergic receptor function using antisense and genetically altered animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Receptor regulation as a unitary mechanism for drug tolerance and physical dependence--not quite as simple as it seemed!

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Mu opioid receptor: a gateway to drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The neurobiology of addiction: a neuroadaptational view relevant for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Impact of psychostimulants on vesicular monoamine transporter function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Neurobiology of addiction: treatment and public policy ramifications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Dopamine responses comply with basic assumptions of formal learning theory

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

A neural substrate of prediction and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Nucleus accumbens shell and core dopamine: differential role in behavior and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Context-specific enhancement of glutamate transmission by cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Immediate early gene expression invoked by electrical intracochlear stimulation in some but not all types of neurons in the rat auditory brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Using immediate-early genes to map hippocampal subregional functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Neuroplasticity in the mesolimbic dopamine system and cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

c-Fos is an intracellular regulator of cocaine-induced long-term changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Decreases in dopamine receptors but not in dopamine transporters in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Overexpression of dopamine D2 receptors reduces alcohol self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Insights from recent positron emission tomographic studies of drug abuse and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Regional brain metabolic activation during craving elicited by recall of previous drug experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Cocaine dependence: a disease of the brain's reward centers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Inhibition of monoamine oxidase by amphetamine and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Amphetamine induces dopamine efflux through a dopamine transporter channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Mechanisms of neurotransmitter release by amphetamines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

A single methamphetamine administration rapidly decreases vesicular dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Prefrontal cortical dysfunction in abstinent cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Intraneuronal dopamine-quinone synthesis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Cloning and expression of a functional serotonin transporter from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Immunohistochemical study of short- and long-term effects of DL-fenfluramine on the serotonergic innervation of the rat hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Neurotoxicity of MDMA and related compounds: anatomic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Does GFAP mRNA and mitochondrial benzodiazepine receptor binding detect serotonergic neuronal degeneration in rat?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: implications for pharmacological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Serotonin transporters upregulate with chronic cocaine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Effect of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Ecstasy and new patterns of drug use: a normal population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

Effects of chronic cocaine abuse on postsynaptic dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15563650.2010.516263

10.3109/15563650.2010.516263

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference